Cover Image
市場調查報告書

止痛藥的全球市場:2016∼2020年

Global Analgesics Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 361553
出版日期 內容資訊 英文 102 Pages
訂單完成後即時交付
價格
Back to Top
止痛藥的全球市場:2016∼2020年 Global Analgesics Market 2016-2020
出版日期: 2016年06月17日 內容資訊: 英文 102 Pages
簡介

止痛藥是以骨折等損傷為首,對疼痛最常開處方的藥物,以疼痛緩和為目的製作。全球止痛藥市場,預計2016∼2020年,以CAG4.28%擴大。

本報告提供全球止痛藥市場現狀與2020年的預測,市場規模與銷售趨勢,彙整主要供應商的競爭環境與簡介。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 產品研發線

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各類藥物市場區隔

  • 類鴉片物質
  • NSAID
  • 其他

第8章 各類型市場區隔

  • 處方藥
  • OTC藥

第9章 各用途市場市場區隔

第10章 疼痛的各類型市場區隔

  • 肌肉骨骼痛
  • 手術、外傷
  • 癌症的疼痛
  • 神經疼痛
  • 偏頭痛
  • 產後通
  • 纖維肌痛
  • 燙傷的疼痛
  • 牙齒/臉的疼痛
  • 小兒科

第11章 各給藥途徑市場區隔

第12章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第13章 推動市場的要素

  • 高齡化
  • 自我治療的增加
  • 有希望的開發平台
  • 有利的法律規章方案

第14章 促進要素的影響

第15章 市場課題

第16章 促進要素與課題的影響

第17章 市場趨勢

第18章 供應商環境

  • 競爭模式
  • 市場佔有率分析:2015年
  • Pfizer
  • Bayer Healthcare
  • Sanofi
  • Endo International
  • Johnson & Johnson
  • Purdue Pharma
  • 其他值得注意的供應商

第19章 附錄

第20章 關於Technavio

目錄
Product Code: IRTNTR9551

About the Analgesics Market

Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.

Technavio's analysts forecast the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global analgesics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of analgesics globally. The report does not include revenue generated from the aftermarket service of the product.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Analgesics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Pfizer
  • Bayer HealthCare
  • Sanofi
  • Endo
  • Johnson & Johnson
  • Purdue Pharma

Other Prominent Vendors

  • Achelios Therapeutics
  • Alder BioPharmaceuticals
  • Allergan
  • Amgen
  • AstraZeneca
  • Baxter
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • CoLucid Pharmaceuticals
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • DURECT
  • El Lilly & Company
  • F. Hoffmann La Roche
  • GlaxoSmithKline
  • GW Pharmaceuticals
  • Hospira
  • Immune Pharmaceuticals
  • Innovative Med Concepts
  • Merck
  • NeurAxon
  • Novartis
  • OptiNose
  • Pain Therapeutics
  • RedHill
  • Sorrento Therapeutics
  • Suda
  • Taro Pharmaceuticals Industries
  • Teva Pharmaceuticals Industries
  • Tonix Pharmaceuticals
  • Trigemina
  • UCB
  • Valeant Pharmaceuticals International
  • WEX Pharmaceuticals
  • Zynerba Pharmaceuticals

Market driver

  • Increase in self-medication
  • For a full, detailed list, view our report

Market challenge

  • Preference for alternative therapies
  • For a full, detailed list, view our report

Market trend

  • Accelerated use of online resources
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Assumptions
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Pain: Overview

PART 05: Pipeline portfolio

  • Information on pipeline candidates

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by drug class

  • Opioids
  • NSAIDs
  • Other
  • Global opioids market
  • Global NSAIDs Market

PART 08: Market segmentation by type

  • Prescription analgesics
  • OTC analgesics

PART 09: Market segmentation by application

  • Global internal analgesics market
  • Global external analgesics market

PART 10: Market segmentation by pain type

  • Musculoskeletal pain
  • Surgical and trauma pain
  • Cancer pain
  • Neuropathic pain
  • Migraine
  • Obstetrical pain
  • Fibromyalgia
  • Pain due to burns
  • Dental/facial pain
  • Pediatric pain

PART 11: Market segmentation by ROA

  • Oral
  • Parenteral
  • Topical
  • Transdermal
  • Rectal

PART 12: Geographical segmentation

  • Analgesics market in Americas
  • Analgesics market in EMEA
  • Analgesics market in APAC

PART 13: Market drivers

  • Growing geriatric population
  • Increase in self-medication
  • Promising pipeline
  • Favorable regulatory scenario

PART 14: Impact of drivers

PART 15: Market challenges

  • Generic competition
  • Preference for alternative therapies
  • Counterfeit pharmaceuticals

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Accelerated use of online resources
  • Increase in R&D
  • Off-label drugs use
  • Strategic alliances

PART 18: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Pfizer
  • Bayer Healthcare
  • Sanofi
  • Endo International
  • Johnson & Johnson
  • Purdue Pharma
  • Other prominent vendors

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Pain assessment
  • Exhibit 03: Types of pain scales
  • Exhibit 04: Treatment options for pain
  • Exhibit 05: Commonly used non-opioids for pain
  • Exhibit 06: Commonly used adjuvant medicines for pain
  • Exhibit 07: Treatment algorithm for pain
  • Exhibit 08: Pipeline portfolio: Major analgesic candidates under development for pain
  • Exhibit 09: Global analgesics market 2015-2020 ($ billions)
  • Exhibit 10: Five forces analysis
  • Exhibit 11: Global analgesics market by drug class
  • Exhibit 12: Segmentation of global analgesics market by drug class 2015
  • Exhibit 13: Global analgesics market segmentation by drug class 2015-2020 ($ billions)
  • Exhibit 14: Global analgesics market segmentation by drug class 2015-2020
  • Exhibit 15: Global analgesics market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
  • Exhibit 16: Global opioids market 2015-2020 ($ billions)
  • Exhibit 17: Global NSAIDs market 2015-2020 ($ billions)
  • Exhibit 18: Global analgesics segmentation by type
  • Exhibit 19: Global analgesics segmentation by type 2015
  • Exhibit 20: Global analgesics market segmentation by type 2015-2020 ($ billions)
  • Exhibit 21: Global analgesics market segmentation by type 2015-2020
  • Exhibit 22: Global analgesics market: YoY revenue and growth based on type 2015-2020 ($ billions)
  • Exhibit 23: Global prescription analgesics market 2015-2020 ($ billions)
  • Exhibit 24: Global OTC analgesics market 2015-2020 ($ billions)
  • Exhibit 25: Global analgesics market segmentation by application
  • Exhibit 26: Global internal analgesics market 2015-2020 ($ billions)
  • Exhibit 27: Global external analgesics market 2015-2020 ($ billions)
  • Exhibit 28: Global analgesics market segmentation by application 2015-2020 ($ billions)
  • Exhibit 29: Global analgesics market segmentation by application 2015-2020
  • Exhibit 30: Global analgesics market: YoY revenue and growth based on application 2015-2020 ($ billions)
  • Exhibit 31: Global analgesics market segmentation by type
  • Exhibit 32: Global analgesics market segmentation by type 2015
  • Exhibit 33: Global analgesics market segmentation by ROA
  • Exhibit 34: Global analgesics market segmentation by ROA 2015
  • Exhibit 35: Global analgesics market by geography 2015
  • Exhibit 36: Global analgesics market revenue by geography 2015-2020 ($ billions)
  • Exhibit 37: Global analgesics market revenue by geography 2015-2020
  • Exhibit 38: Global analgesics market: YoY revenue and growth based on geography 2015-2020 ($ billions)
  • Exhibit 39: Analgesics market in Americas 2015-2020 ($ billions)
  • Exhibit 40: Analgesics market in EMEA 2015-2020 ($ billions)
  • Exhibit 41: Analgesics market in APAC 2015-2020 ($ billions)
  • Exhibit 42: Population aged 60 years and over: World, developed, and developing regions (millions)
  • Exhibit 43: Expected growth of older population in US 2010-2050
  • Exhibit 44: Impact of drivers
  • Exhibit 45: Alternative therapies for pain
  • Exhibit 46: Use of CAM therapies among individuals in US
  • Exhibit 47: Impact of drivers and challenges
  • Exhibit 48: Global Internet penetration rate 2015
  • Exhibit 49: Market share analysis 2015
  • Exhibit 50: Revenue share of major companies for global analgesics market 2015
  • Exhibit 51: Revenues from the sales of top five analgesics 2013-2015 ($ millions)
  • Exhibit 52: Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
  • Exhibit 53: Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
  • Exhibit 54: Pfizer: YoY revenue and growth rate of Relpax 2013-2015 ($ millions)
  • Exhibit 55: Pfizer: Key takeaways
  • Exhibit 56: Bayer HealthCare: YoY revenue and growth rate of Aspirin 2013-2015 ($ millions)
  • Exhibit 57: Bayer HealthCare: YoY revenue and growth rate of Aleve 2013-2015 ($ millions)
  • Exhibit 58: Bayer HealthCare: Key takeaways
  • Exhibit 59: Sanofi: YoY revenue and growth rate of Doliprane 2013-2015 ($ millions)
  • Exhibit 60: Sanofi: YoY revenue and growth rate of Dorflex 2013-2015 ($ millions)
  • Exhibit 61: Sanofi: YoY revenue and growth rate of Synvisc/Synvisc One 2013-2015 ($ millions)
  • Exhibit 62: Sanofi: YoY revenue and growth rate of No Spa 2013-2015 ($ millions)
  • Exhibit 63: Sanofi: Key takeaways
  • Exhibit 64: Endo International: YoY revenue and growth rate of Opana ER 2013-2015 ($ millions)
  • Exhibit 65: Endo International: YoY revenue and growth rate of Voltaren 2013-2015 ($ millions)
  • Exhibit 66: Endo International: YoY revenue and growth rate of Lidoderm 2013-2015 ($ millions)
  • Exhibit 67: Endo International: YoY revenue and growth rate of Percocet 2013-2015 ($ millions)
  • Exhibit 68: Endo International: Key takeaways
  • Exhibit 69: Johnson & Johnson: Key takeaways
  • Exhibit 70: Purdue Pharma: Key takeaways
Back to Top